Insider · CIK 0001977361

Dubovsky Filip

Reports to the SEC for 1 company · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001977361

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-17	NVAXNOVAVAX INCS Sale	President, R&D	SSale	−12.5K sh	$14.46	−$181K	68,017
2024-06-17	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+12.5K sh	$6.09	+$76.1K	80,517
2024-06-17	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+1,404 sh	$6.97	+$9,785.88	68,017
2024-06-17	NVAXNOVAVAX INC · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−12.5K sh	$6.09	−$76.1K	37,500
2024-06-17	NVAXNOVAVAX INC · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−1,404 sh	$6.97	−$9,785.88	46,324
2024-06-17	NVAXNOVAVAX INCS Sale	President, R&D	SSale	−1,404 sh	$14.54	−$20.4K	66,613
2024-05-14	NVAXNOVAVAX INC · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−19.7K sh	—	—	47,728
2024-05-14	NVAXNOVAVAX INCS Sale	President, R&D	SSale	−47.3K sh	$13.90	−$658K	38,953
2024-05-14	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+19.7K sh	$6.97	+$137K	86,265
2024-03-10	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+5,376 sh	—	—	69,210
2024-03-10	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	President, R&D	MExercise/Conversion	−5,376 sh	—	—	5,376
2024-03-10	NVAXNOVAVAX INCF Tax Payment	President, R&D	FTax Payment	−2,597 sh	$5.45	−$14.2K	66,613
2024-03-07	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	President, R&D	MExercise/Conversion	−19.4K sh	—	—	0
2024-03-07	NVAXNOVAVAX INCF Tax Payment	President, R&D	FTax Payment	−9,392 sh	$5.61	−$52.7K	63,834
2024-03-07	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+19.4K sh	—	—	73,226
2024-03-01	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	President, R&D	AAward	+144K sh	—	—	144,000
2023-12-14	NVAXNOVAVAX INCF Tax Payment	President, R&D	FTax Payment	−1,368 sh	$5.69	−$7,783.92	53,782
2023-12-14	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+2,833 sh	$5.69	+$16.1K	55,150
2023-12-14	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	President, R&D	MExercise/Conversion	−2,833 sh	—	—	0
2023-11-05	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+1,400 sh	$7.06	+$9,884	52,994
2023-11-05	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	President, R&D	MExercise/Conversion	−1,400 sh	—	—	0
2023-11-05	NVAXNOVAVAX INCF Tax Payment	President, R&D	FTax Payment	−677 sh	$7.06	−$4,779.62	52,317
2023-09-16	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	President, R&D	MExercise/Conversion	−12.6K sh	—	—	0
2023-09-16	NVAXNOVAVAX INCF Tax Payment	President, R&D	FTax Payment	−6,108 sh	$7.71	−$47.1K	51,594
2023-09-16	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+12.6K sh	$7.71	+$97.5K	57,702
2023-06-16	NVAXNOVAVAX INCM Exercise/Conversion	President, R&D	MExercise/Conversion	+4,155 sh	$8.04	+$33.4K	47,065
2023-06-16	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	President, R&D	MExercise/Conversion	−4,155 sh	—	—	0
2023-06-16	NVAXNOVAVAX INCF Tax Payment	President, R&D	FTax Payment	−2,007 sh	$8.04	−$16.1K	45,058

Recent filings

Accepted (ET)
Jun 204
Dubovsky Filip0001593968-24-000879
SEC(opens sec.gov)
May 154
Dubovsky Filip0001104659-24-062148
SEC(opens sec.gov)
Mar 264
Dubovsky Filip0001104659-24-039163
SEC(opens sec.gov)
Mar 124
Dubovsky Filip0001104659-24-033620
SEC(opens sec.gov)
Mar 114
Dubovsky Filip0001104659-24-033165
SEC(opens sec.gov)
Dec 184
Dubovsky Filip0001209191-23-058982
SEC(opens sec.gov)
Nov 74
Dubovsky Filip0001209191-23-054625
SEC(opens sec.gov)

Companies

NOVAVAX INCPresident, R&DNVAX

Address

C/O NOVAVAX, INC. 700 QUINCE ORCHARD ROAD

GAITHERSBURG, MD, 20878